(Q28582508)

2

1 reference

31 January 2017

R. A. Shorthouse

3

1 reference

31 January 2017

M. Löffler

4

1 reference

31 January 2017

R. E. Morris

Transplantation Proceedings

5

1 reference

31 January 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

31 January 2017

1 reference

31 January 2017

29

1 reference

31 January 2017

1292–1293

1 reference

31 January 2017

1-2

1 reference

31 January 2017

Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900523-4

7 January 2021

Immunopharmacological profile of HWA 486, a novel isoxazol derivative--II. In vivo immunomodulating effects differ from those of cyclophosphamide, prednisolone, or cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900523-4

7 January 2021

Leflunomide, a novel immunosuppressive agent. The mechanism of inhibition of T cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900523-4

7 January 2021

Regulation of B cell function by the immunosuppressive agent leflunomide

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900523-4

7 January 2021

Inhibition of smooth muscle cell proliferation in vitro by leflunomide, a new immunosuppressant, is antagonized by uridine

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900523-4

7 January 2021

Inhibition of the epidermal growth factor receptor tyrosine kinase activity by leflunomide

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900523-4

7 January 2021

Inhibition of Protein Tyrosine Phosphorylation in T Cells by a Novel Immunosuppressive Agent, Leflunomide

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900523-4

7 January 2021

Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomide

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900523-4

7 January 2021

Dihydroorotate dehydrogenase is a high affinity binding protein for A77 1726 and mediator of a range of biological effects of the immunomodulatory compound

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900523-4

7 January 2021

The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900523-4

7 January 2021

Leflunomide interferes with pyrimidine nucleotide biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900523-4

7 January 2021

Catalytic enzyme histochemistry and biochemical analysis of dihydroorotate dehydrogenase/oxidase and succinate dehydrogenase in mammalian tissues, cells and mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900523-4

7 January 2021